Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
4.09%
↓ 76% below average
Average (28q)
16.71%
Historical baseline
Range
High:310.83%
Low:-54.55%
Volatility
2186.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 4.09% |
| Q2 2025 | 14.52% |
| Q1 2025 | 12.24% |
| Q4 2024 | 10.00% |
| Q3 2024 | 16.05% |
| Q2 2024 | 12.50% |
| Q1 2024 | -0.48% |
| Q4 2023 | 45.74% |
| Q3 2023 | 27.28% |
| Q2 2023 | 18.67% |
| Q1 2023 | 13.23% |
| Q4 2022 | 48.59% |
| Q3 2022 | 7.41% |
| Q2 2022 | 35.62% |
| Q1 2022 | 310.83% |
| Q4 2021 | -37.24% |
| Q3 2021 | -54.55% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |